AKT1 and cancer: ABI1 plays a multi-regulatory role in this context, enabling signaling crosstalk to affect processes including phosphoinositide 3-kinase (PI3K), EGFR, WRC-mediated cytoskeletal remodeling, and protein kinase B (AKT)-mediated cell survival and proliferation pathways dysregulated in cancer [21–26].